Programme highlights: emerging infections

Respiratory infections with pandemic and epidemic potential have been a burden to the human race for as long as history has recorded. Globally, respiratory infections are among the most common cause of morbidity and mortality. While treatments and prevention strategies have been applied, the emergence of antimicrobial resistance threatens the progress that has been made. Additionally, new respiratory infections, particularly linked to interactions between humans and animals, are also emerging.

This year's Congress puts the spotlight on the most up-to-date scientific developments in, and challenges relating to, respiratory infections. There are a number of sessions available, including postgraduate courses, challenging clinical cases, meet the expert sessions, oral presentations, symposia, hot topics, poster discussions and a dedicated assembly group members meeting.

Stefano Aliberti, Head of the ERS Respiratory Infections Assembly, notes: "Antimicrobial resistance and emerging infections threaten the effective management and prevention of a range of respiratory infections, which already represent a significant burden to healthcare services. It is vital that we understand developments in this field if we are to overcome this global public health threat. Sessions at this year's Congress will focus on infection control in epidemics, the treatment of extensively drug-resistant TB and updates in the field of pneumonia and chronic infections, among other topics."
Join the ERS Respiratory Infections Assembly on MyERS.

If you are interested in this topic, here is a list of some associated sessions at this year's Congress. Alternatively, you can browse the full programme and filter your search by 'Infection' for more sessions on this topic.

Note: Educational sessions (postgraduate courses, skills workshops, challenging clinical cases, professional development workshops and meet the expert sessions) can be attended at an additional cost to the standard registration fee.

Date Time Session Session type
03.09.2016 09:30 to 13:00 PG10 Tuberculosis management: a personalised clinical approach Postgraduate course
03.09.2016 09:30 to 13:00 PG9 Recurrent respiratory infections in both children and adults Postgraduate course
03.09.2016 14:00 to 17:30 PG13 Inhaled antibiotics in respiratory infections Postgraduate course
03.09.2016 14:00 to 17:30 PG16 Infection control in epidemics: strengthening the evidence base for healthcare workers and the public: Joint PREPARE/ECDC courseJoint PREPARE/ECDC course Postgraduate course
04.09.2016 10:45 to 12:45 ERS and tuberculosis: 2016 highlights (followed by WHO/ERS document ceremony) Symposium
04.09.2016 13:00 to 14:15 Assembly 10 Respiratory infections: includes groups 10.1 Respiratory infections, and 10.2 Tuberculosis Assembly members' meeting
05.09.2016 07:00 to 08:15 CC5 Non-resolving pneumonia Challenging clinical cases
05.09.2016 08:30 to 10:30 Diseases and defences of the respiratory mucosa: A joint ERS/SMI symposium Symposium
05.09.2016 8:30 to 10:30 An update on pleural empyema diagnostics and treatment Symposium
05.09.2016 10:45 to 12:45 Influenza and respiratory physicians Symposium
05.09.2016 13:00 to 14:00 ME8 Acute and chronic infection in chronic obstructive pulmonary disease Meet the expert
05.09.2016 14:45 to 16:45 New therapies for chronic respiratory infections Symposium
06.09.2016 07:00 to 08:15 CC8 Complex management issues in ataxia telangiectasia Challening clinical cases
06.09.2016 08:30 to 10:30 The problem of multidrug-resistant tuberculosis Symposium
06.09.2016 10:45 to 12:45 Microbiome in health and in disease Symposium
06.09.2016 14: 45 to 16:45 Respiratory infectious disease control in Europe: ERS/ECDC joint sessionERS/ECDC joint session Session
07.09.2016 08:30 to 10:30 Respiratory infections in high-income countries: old challenges and new threats Symposium
07.09.2016 08:30 to 10:30 Immunity in COPD: Time for questions? Hot topics